Funds and ETFs Pharmaron Beijing Co., Ltd.
Equities
300759
CNE100003JW4
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.37 CNY | -3.22% | -3.91% | -26.26% |
05-20 | Pharmaron Beijing Unit to Sell Proteologix Stake to Johnson & Johnson | MT |
04-30 | Pharmaron Beijing's Profit Rises 17% in 2023 | MT |
ETFs positioned on Pharmaron Beijing Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.17% | 2 M€ | -16.67% | - | |
0.13% | 35 M€ | -5.85% | - | |
0.10% | 3 M€ | +4.49% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 4 M€ | -11.56% | ||
0.03% | 7 M€ | -.--% | - | |
0.01% | 112 M€ | +4.73% | - | |
0.01% | 2,867 M€ | +10.11% | - | |
0.01% | 454 M€ | +8.42% | - | |
0.01% | 153 M€ | +7.93% | - | |
0.00% | 4 M€ | -4.41% | - | |
0.00% | 45 M€ | 0.00% | - | |
0.00% | 7 M€ | +5.78% | - | |
0.00% | 34 M€ | +4.01% | - | |
0.00% | 15 M€ | +21.38% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.26% | 4.94B | |
+65.24% | 62.59B | |
-1.34% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.30% | 26.21B | |
-21.75% | 19.09B | |
+4.98% | 13.08B | |
+25.59% | 12.26B | |
+28.44% | 12.05B |
- Stock Market
- Equities
- 300759 Stock
- Funds and ETFs Pharmaron Beijing Co., Ltd.